Synthetopes Inc – FDA 483, May 16, 2019
Synthetopes Inc, a producer of sterile drugs in Conway, SC, was cited for significant deficiencies in its manufacturing processes during an FDA inspection. The firm failed to conduct essential sterility and potency testing for its radiological and nuclear injectable drug products, lacked validation for aseptic processes and sterilization, and exhibited poor environmental monitoring and equipment sanitation. These issues indicate a severe lack of control over microbiological contamination and product quality, raising concerns about the safety and efficacy of its sterile drug products.
ID · 90d41bdf-b76a-4990-9713-a22ebe38660d
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.